N-[1-[4-[3-cyano-6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-4-yl]phenyl]-3-methylazetidin-3-yl]prop-2-enamide

C25H23N7O — CID 171521008

IUPACN-[1-[4-[3-cyano-6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-4-yl]phenyl]-3-methylazetidin-3-yl]prop-2-enamide
SMILESC=CC(=O)NC1(C)CN(c2ccc(-c3cc(-c4cnn(C)c4)cn4ncc(C#N)c34)cc2)C1
InChIInChI=1S/C25H23N7O/c1-4-23(33)29-25(2)15-31(16-25)21-7-5-17(6-8-21)22-9-18(20-12-27-30(3)13-20)14-32-24(22)19(10-26)11-28-32/h4-9,11-14H,1,15-16H2,2-3H3,(H,29,33)
InChIKeyHYRJMNOXKQHCHO-UHFFFAOYSA-N
MW437.51 g/mol
LogP3.15
Rot. Bonds5

About N-[1-[4-[3-cyano-6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-4-yl]phenyl]-3-methylazetidin-3-yl]prop-2-enamide

N-[1-[4-[3-cyano-6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-4-yl]phenyl]-3-methylazetidin-3-yl]prop-2-enamide (PubChem CID 171521008) has the molecular formula C25H23N7O and a molecular weight of 437.51 g/mol. Its IUPAC name is N-[1-[4-[3-cyano-6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-4-yl]phenyl]-3-methylazetidin-3-yl]prop-2-enamide.

Molecular Properties

Compound NameN-[1-[4-[3-cyano-6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-4-yl]phenyl]-3-methylazetidin-3-yl]prop-2-enamide
PubChem CID171521008
Molecular FormulaC25H23N7O
Molecular Weight437.51 g/mol
Exact Mass437.20
IUPAC NameN-[1-[4-[3-cyano-6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-4-yl]phenyl]-3-methylazetidin-3-yl]prop-2-enamide
SMILESC=CC(=O)NC1(C)CN(c2ccc(-c3cc(-c4cnn(C)c4)cn4ncc(C#N)c34)cc2)C1
InChIInChI=1S/C25H23N7O/c1-4-23(33)29-25(2)15-31(16-25)21-7-5-17(6-8-21)22-9-18(20-12-27-30(3)13-20)14-32-24(22)19(10-26)11-28-32/h4-9,11-14H,1,15-16H2,2-3H3,(H,29,33)
InChIKeyHYRJMNOXKQHCHO-UHFFFAOYSA-N
XLogP3.15
TPSA91.25 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds5
Heavy Atoms33
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500437.51
LogP ≤ 53.15
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze N-[1-[4-[3-cyano-6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-4-yl]phenyl]-3-methylazetidin-3-yl]prop-2-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[1-[4-[3-cyano-6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-4-yl]phenyl]-3-methylazetidin-3-yl]prop-2-enamide?
The IUPAC name of N-[1-[4-[3-cyano-6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-4-yl]phenyl]-3-methylazetidin-3-yl]prop-2-enamide (CID 171521008) is N-[1-[4-[3-cyano-6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-4-yl]phenyl]-3-methylazetidin-3-yl]prop-2-enamide.
What is the SMILES notation for N-[1-[4-[3-cyano-6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-4-yl]phenyl]-3-methylazetidin-3-yl]prop-2-enamide?
The canonical SMILES for N-[1-[4-[3-cyano-6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-4-yl]phenyl]-3-methylazetidin-3-yl]prop-2-enamide is C=CC(=O)NC1(C)CN(c2ccc(-c3cc(-c4cnn(C)c4)cn4ncc(C#N)c34)cc2)C1.
What is the InChIKey of N-[1-[4-[3-cyano-6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-4-yl]phenyl]-3-methylazetidin-3-yl]prop-2-enamide?
The InChIKey is HYRJMNOXKQHCHO-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H23N7O/c1-4-23(33)29-25(2)15-31(16-25)21-7-5-17(6-8-21)22-9-18(20-12-27-30(3)13-20)14-32-24(22)19(10-26)11-28-32/h4-9,11-14H,1,15-16H2,2-3H3,(H,29,33).
What are the key properties of N-[1-[4-[3-cyano-6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-4-yl]phenyl]-3-methylazetidin-3-yl]prop-2-enamide?
N-[1-[4-[3-cyano-6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-4-yl]phenyl]-3-methylazetidin-3-yl]prop-2-enamide has a molecular weight of 437.51 g/mol, XLogP of 3.15, 5 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-[4-[3-cyano-6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-4-yl]phenyl]-3-methylazetidin-3-yl]prop-2-enamide is sourced from PubChem (CID 171521008), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).